Inclusion Criteria:
  -  1. Patient with hemodynamic corrected valvular atrial fibrillation who is scheduled for ablation procedure and ≥20 and ≤80 years of age
  -  2. Left atrium size < 50mm
  -  3. paroxysmal atrial fibrillation that is recurrence during antiarrhythmic drug treatment or is not able to use an antiarrhythmic drug.
  -  4. Patient who is indicated for anticoagulation therapy (for prevention of cerebral infarction)
Exclusion Criteria:
  -  1. Patients with permanent atrial fibrillation
  -  2. Atrial fibrillation associated with severe cardiac malformation or a structural heart disease that is hemodynamically affected
  -  3. Patients with severe renal impairment or CT imaging difficulty using contrast media
  -  4. Patients with a past history of radiofrequency ablation for atrial fibrillation or other cardiac surgery
  -  5. Patients with active internal bleeding
  -  6. Patients with contraindications for anticoagulation therapy(for prevention of cerebral infarction) and antiarrhythmic drugs
  -  7. Patients with non-valvular atrial fibrillation
  -  8. Patients with a severe comorbid disease
  -  9. Expected survival < 1 year
  -  10. Drug addicts or alcoholics
  -  11. Patients who cannot read the consent form (illiterates, foreigners, etc.)
  -  12. Other patients who are judged by the principal or sub-investigator to be ineligible for participation in this clinical study